![Murray Stewart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 27 511 $ al 31/05/2026
Murray Willis Stewart currently works at X4 Pharmaceuticals, Inc., as Independent Director from 2023, Vivli Center For Global Clinical Research Data, as Director, VectivBio AG, as Director, and CAMP4 Therapeutics Corp., as Independent Director from 2025.
Dr. Stewart also formerly worked at Amarin Corp.
Plc, as Independent Director in 2023, VectivBio Holding AG, as Independent Director from 2021 to 2023, Rhythm Pharmaceuticals, Inc., as Chief Medical Officer from 2018 to 2021, GSK Plc, as Chief Medical Officer from 2014 to 2017, and Novelion Therapeutics, Inc., as Executive VP, Head-Research & Development from 2017 to 2018.
Dr. Stewart received his doctorate degree from The University of Southampton.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC. 0,01 % | 01/03/2026 | 6.383 ( 0,01 % ) | 27 511 $ | 31/05/2026 |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 29/03/2019 |
| CAMP4 THERAPEUTICS CORPORATION | Director/Miembro de la Junta | 18/03/2025 |
Vivli Center For Global Clinical Research Data
 Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Director/Miembro de la Junta | - |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| VECTIVBIO HOLDING AG | Director/Miembro de la Junta | 26/06/2023 |
| AMARIN CORPORATION PLC | Director/Miembro de la Junta | 06/03/2023 |
| RHYTHM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 10/09/2021 |
| NOVELION THERAPEUTICS INC. | Director Técnico/Científico/I+D | 17/10/2018 |
| GSK PLC | Director Técnico/Científico/I+D | 01/11/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Vivli Center For Global Clinical Research Data
Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Technology Services |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
